2012 Fall Meeting of the APS Division of Nuclear Physics
Volume 57, Number 9
Wednesday–Saturday, October 24–27, 2012;
Newport Beach, California
Session JA: Neutron-rich Nuclei, r-Process Nuclei, and Radioisotopes
10:30 AM–12:18 PM,
Friday, October 26, 2012
Room: Plaza I
Chair: Barry Davids, TRIUMF
Abstract ID: BAPS.2012.DNP.JA.3
Abstract: JA.00003 : Radioisotope Production for Medical and Physics Applications*
11:42 AM–12:18 PM
Preview Abstract
Abstract
Author:
Leonard Mausner
(Collider Accelerator Department Brookhaven National Laboratory)
Radioisotopes are critical to the science and technology base of the US.
Discoveries and applications made as a result of the availability of
radioisotopes span widely from medicine, biology, physics, chemistry and
homeland security. The clinical use of radioisotopes for medical diagnosis
is the largest sector of use, with about 16 million procedures a year in the
US. The use of $^{99}$Mo/$^{99m}$Tc generator and $^{18}$F make up the
majority, but $^{201}$Tl, $^{123}$I, $^{111}$In, and $^{67}$Ga are also used
routinely to perform imaging of organ function. Application of radioisotopes
for therapy is dominated by use of $^{131}$I for thyroid malignancies,
$^{90}$Y for some solid tumors, and $^{89}$Sr for bone cancer, but
production of several more exotic species such as $^{225}$Ac and $^{211}$At
are of significant current research interest. In physics $^{225}$Ra is of
interest for CP violation studies, and the actinides $^{242}$Am, $^{249}$Bk,
and $^{254}$Es are needed as targets for experiments to create superheavy
elements. Large amounts of $^{252}$Cf are needed as a fission source for the
CARIBU experiment at ANL. The process of radioisotope production is
multidisciplinary. Nuclear physics input based on nuclear reaction
excitation function data is needed to choose an optimum target/projectile in
order to maximize desired isotope production and minimize unwanted
byproducts. Mechanical engineering is needed to address issues of target
heating, induced mechanical stress and material compatibility of target and
claddings. Radiochemists are involved as well since chemical separation to
purify the desired final radioisotope product from the bulk target and
impurities is also usually necessary. Most neutron rich species are produced
at a few government and university reactors. Other radioisotopes are
produced in cyclotrons in the commercial sector, university/hospital based
facilities, and larger devices at the DOE labs. The landscape of US
facilities, the techniques involved, and current supply challenges will be
reviewed.
*Support from DOE Office of Nuclear Physics under contract No.DE-AC02-98CH1-886
To cite this abstract, use the following reference: http://meetings.aps.org/link/BAPS.2012.DNP.JA.3